2017
The Gαi-GIV binding interface is a druggable protein-protein interaction
Abstract: Heterotrimeric G proteins are usually activated by the guanine-nucleotide exchange factor (GEF) activity of GPCRs. However, some non-receptor proteins are also GEFs. GIV (a.k.a Girdin) was the first non-receptor protein for which the GEF activity was ascribed to a well-defined protein sequence that directly binds Gαi. GIV expression promotes metastasis and disruption of its binding to Gαi blunts the pro-metastatic behavior of cancer cells. Although this suggests that inhibition of the Gαi-GIV interaction is a …
Search citation statements
Paper Sections
Select...
22
4
3
1
Citation Types
3
25
0
2
Year Published
2017
2026
Publication Types
Select...
19
4
3
2
Relationship
7
21
Authors
Journals
Cited by 27 publications
(30 citation statements)
References 74 publications
3
25
0
2
“…Concentration-dependent binding curves revealed that the affinity of Gαi3 for the dark conformation of LOV2GIVe is orders of magnitude weaker than for the lit conformation ( Figure 2A ), which had an equilibrium dissociation constant (K D ) similar to that previously reported for the GIV-Gαi3 interaction ( DiGiacomo et al, 2017 ). We also found that LOV2GIVe retains the same G-protein specificity as GIV.…”
Section: Resultssupporting
confidence: 77%
“…Concentration-dependent binding curves revealed that the affinity of Gαi3 for the dark conformation of LOV2GIVe is orders of magnitude weaker than for the lit conformation ( Figure 2A ), which had an equilibrium dissociation constant (K D ) similar to that previously reported for the GIV-Gαi3 interaction ( DiGiacomo et al, 2017 ). We also found that LOV2GIVe retains the same G-protein specificity as GIV.…”
Section: Resultssupporting
confidence: 77%
“…Concentration-dependent binding curves revealed that the affinity of Gαi3 for the dark conformation of LOV2GIVe is orders of magnitude weaker than for the lit conformation ( Fig. 2A), which had an equilibrium dissociation constant (Kd) similar to that previously reported for the GIV-Gαi3 interaction (DiGiacomo et al, 2017). We also found that LOV2GIVe retains the same G-protein specificity as GIV.…”
Section: Lov2give Binds and Activates G-proteins Efficiently In Vitrosupporting
confidence: 82%
“…These compounds were frequently associated with modulator properties. Overall, the analysis of this interface has shown that especially the Switch II/α3 region is well exposed and druggable, which has already been described by DiGiacomo et al [188] . in the context of small molecules, but can further be extended to the peptide level.…”
Section: Discussionsupporting
confidence: 61%
